GSA Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	51,198 +22,998	+82%	+$550K	0.07%	418
2025 Q4	$753K	Sell	28,200 -47,702	-63%	-$1.14M	0.06%	541
2025 Q3	$1.62M	Buy	75,902 +51,428	+210%	+$1.22M	0.14%	149
2025 Q2	$528K	Sell	24,474 -54,819	-69%	-$1.02M	0.04%	878
2025 Q1	$1.32M	Buy	79,293 +5,766	+8%	+$105K	0.12%	219
2024 Q4	$1.35M	Buy	73,527 +6,431	+10%	+$104K	0.1%	234
2024 Q3	$1.03M	Sell	67,096 -113,604	-63%	-$1.9M	0.08%	449
2024 Q2	$2.94M	Buy	180,700 +69,306	+62%	+$1.12M	0.21%	46
2024 Q1	$2.06M	Buy	111,394 +97,987	+731%	+$2.43M	0.16%	93
2023 Q4	$420K	Sell	13,407 -66,442	-83%	-$1.59M	0.04%	909
2023 Q3	$1.66M	Buy	79,849 +57,119	+251%	+$1.55M	0.14%	166
2023 Q2	$544K	Buy	+22,730	New	+$505K	0.05%	693
2022 Q3	–	Sell	-30,447	Closed	-$429K	–	1465
2022 Q2	$429K	Buy	+30,447	New	+$568K	0.06%	592
2021 Q4	–	Sell	-68,330	Closed	-$1.14M	–	1369
2021 Q3	$1.14M	Buy	+68,330	New	+$1.32M	0.12%	250
2020 Q1	–	Sell	-9,486	Closed	-$406K	–	1000
2019 Q4	$406K	Sell	9,486 -1,152	-11%	-$50.1K	0.05%	803
2019 Q3	$383K	Buy	+10,638	New	+$323K	0.05%	721
2018 Q4	–	Sell	-11,717	Closed	-$243K	–	1299
2018 Q3	$243K	Buy	+11,717	New	+$184K	0.01%	1413
2016 Q1	–	Sell	-9,731	Closed	-$347K	–	1627
2015 Q4	$347K	Sell	9,731 -24,977	-72%	-$880K	0.02%	1384
2015 Q3	$1.15M	Sell	34,708 -7,369	-18%	-$307K	0.06%	548
2015 Q2	$1.76M	Sell	42,077 -27,218	-39%	-$1.05M	0.07%	471
2015 Q1	$2.26M	Buy	69,295 +58,062	+517%	+$2M	0.09%	278
2014 Q4	$357K	Buy	+11,233	New	+$319K	0.02%	1160
2014 Q2	–	Sell	-24,751	Closed	-$602K	–	1775
2014 Q1	$602K	Buy	+24,751	New	+$626K	0.04%	655